
Commentary|Podcasts|January 31, 2025
New Opportunities in Topical Glaucoma Management
Author(s)Mitch Ibach, OD, FAAO, Jessica Steen, OD, FAAO
A newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
What to know before overseeing the manufacturing, patenting process for clinical devices
2
Bausch + Lomb launches preservative-free version of Blink Triple Care eye drops
3
Study takeaways: What new research on retinal cell communication means for eye care
4
Practical tips and tricks: Drs Jeffrey J. Walline, Erin Tomiyama weigh in on myopia management
5




















